Related Experiment Video

Updated: Jun 26, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
08:28

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Published on: February 15, 2022

Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells

Natalia N Mendelev1, Verietta S Williams, David A Tulis

  • 1Cardiovascular Disease Research Program, J.L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, NC, USA.

Journal of Cardiovascular Pharmacology
|February 4, 2009
PubMed

Insights

BAY 41-2272, a novel soluble guanylate cyclase stimulator, effectively inhibits vascular smooth muscle cell growth. This agent modulates cell cycle regulators and cyclic nucleotide signaling, suggesting therapeutic potential for vascular diseases.

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Pharmacology

Background:

  • Vascular smooth muscle (VSM) growth is a key factor in blood vessel diseases.
  • Cyclic nucleotide signaling pathways are recognized for their protective roles in cardiovascular tissues.

Purpose of the Study:

  • To investigate the effects of BAY 41-2272, a soluble guanylate cyclase stimulator, on VSM cell proliferation.
  • To elucidate the underlying molecular mechanisms of BAY 41-2272's action on VSM cells.

Main Methods:

  • Treatment of rat A7R5 VSM cells with BAY 41-2272.
  • Analysis of cell proliferation, cyclic nucleotide levels (cGMP and cAMP), protein kinase activity, and cell cycle regulatory protein expression.
  • Assessment of vasodilator-stimulated phosphoprotein (VASP) phosphorylation and focal adhesion kinase (FAK) phosphorylation.

Main Results:

  • BAY 41-2272 significantly reduced VSM cell proliferation in a dose- and time-dependent manner.
  • The agent increased intracellular cGMP and cAMP levels, activated relevant protein kinases, and altered VASP phosphorylation.
  • BAY 41-2272 modulated the expression of key cell cycle proteins, including cyclins and cyclin-dependent kinase inhibitors, and reduced phosphorylated FAK.

Conclusions:

  • BAY 41-2272 exhibits significant anti-proliferative and cell cycle-regulatory effects on vascular smooth muscle cells.
  • These findings highlight BAY 41-2272 as a potential therapeutic agent for vascular diseases driven by VSM growth.
  • Further investigation of BAY 41-2272 in cardiovascular research is warranted.

More Related Videos

Isolation of Microvascular Endothelial Tubes from Mouse Resistance Arteries09:23

Isolation of Microvascular Endothelial Tubes from Mouse Resistance Arteries

Published on: November 25, 2013

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...